JP2003513668A - ６個のヒト分泌タンパク質 - Google Patents

６個のヒト分泌タンパク質

Info

Publication number
JP2003513668A
JP2003513668A JP2001537495A JP2001537495A JP2003513668A JP 2003513668 A JP2003513668 A JP 2003513668A JP 2001537495 A JP2001537495 A JP 2001537495A JP 2001537495 A JP2001537495 A JP 2001537495A JP 2003513668 A JP2003513668 A JP 2003513668A
Authority
JP
Japan
Prior art keywords
polypeptide
seq
sequence
antibody
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001537495A
Other languages
English (en)
Japanese (ja)
Inventor
スティーブン エム． ルーベン，
ジョージ エイ． コマットソウリス，
ジアン ニ，
ダニエル アール． ソペット，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of JP2003513668A publication Critical patent/JP2003513668A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2001537495A 1999-11-12 2000-11-08 ６個のヒト分泌タンパク質 Withdrawn JP2003513668A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16473199P 1999-11-12 1999-11-12
US60/164,731 1999-11-12
US21513200P 2000-06-30 2000-06-30
US60/215,132 2000-06-30
PCT/US2000/030657 WO2001034799A1 (en) 1999-11-12 2000-11-08 6 human secreted proteins

Publications (1)

Publication Number Publication Date
JP2003513668A true JP2003513668A (ja) 2003-04-15

Family

ID=26860801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001537495A Withdrawn JP2003513668A (ja) 1999-11-12 2000-11-08 ６個のヒト分泌タンパク質

Country Status (5)

Country Link
EP (1) EP1235907A4 (de)
JP (1) JP2003513668A (de)
AU (1) AU1473801A (de)
CA (1) CA2388912A1 (de)
WO (1) WO2001034799A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010980A2 (en) * 2006-07-14 2008-01-24 Thallion Pharmaceuticals Incorporated Tat-049 and methods of assessing and treating cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580753A (en) * 1989-05-23 1996-12-03 Ludwig Institute For Cancer Research DNA encoding the human cytokine, interleukin-9
JPH10512440A (ja) * 1994-12-06 1998-12-02 イミュネックス・コーポレーション サイトカイン”ｌｅｒｋ−７”
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
ES2267192T3 (es) * 1997-08-01 2007-03-01 Serono Genetics Institute S.A. Ests 5' para proteinas secretadas no especificas de tejido.
JP2002543785A (ja) * 1999-05-11 2002-12-24 インサイト・ゲノミックス・インコーポレイテッド 細胞外マトリックス及び接着関連タンパク質
AU4851900A (en) * 1999-06-09 2000-12-28 Genentech Inc. Compositions and methods for the treatment of tumor
AU6101200A (en) * 1999-07-16 2001-02-05 Gene Logic, Inc. Novel cdnas associated with renal disease

Also Published As

Publication number Publication date
EP1235907A1 (de) 2002-09-04
CA2388912A1 (en) 2001-05-17
EP1235907A4 (de) 2003-07-30
AU1473801A (en) 2001-06-06
WO2001034799A1 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
JP5583308B2 (ja) ２１個のヒト分泌タンパク質
JP2003511012A (ja) ３２個のヒト分泌タンパク質
JP2003528587A (ja) ２７個のヒト分泌タンパク質
JP2003514541A (ja) １８個のヒト分泌タンパク質
JP2002532083A (ja) ４７個のヒト分泌タンパク質
JP2003513662A (ja) １５個のヒト分泌タンパク質
JP2003507030A (ja) １８個のヒト分泌タンパク質
JP2003513622A (ja) １９個のヒト分泌タンパク質
JP2003514543A (ja) ２３個のヒト分泌タンパク質
JP2003521242A (ja) １９個のヒト分泌タンパク質
JP2003528586A (ja) ３２個のヒト分泌タンパク質
JP2003535570A (ja) ５０個のヒト分泌タンパク質
JP2003510028A (ja) ２５個のヒト分泌タンパク質
JP2003501072A (ja) ２６個のヒト分泌タンパク質
JP2003502017A (ja) ４９個のヒト分泌タンパク質
JP2003520030A (ja) ２８個のヒト分泌タンパク質
JP2003510074A (ja) ２６個のヒト分泌タンパク質
JP2003528580A (ja) ヒトニューロペプチドレセプター
JP2003520032A (ja) ２４個のヒト分泌タンパク質
JP2003526337A (ja) ２９個のヒト分泌タンパク質
JP2003510062A (ja) ４３個のヒト分泌タンパク質
JP2003532383A (ja) ヒトポリヌクレオチド、ポリペプチド、および抗体
JP2003523726A (ja) ５０個のヒト分泌タンパク質
JP2002539778A (ja) ４９個のヒト分泌タンパク質
JP2003520031A (ja) ２８個のヒト分泌タンパク質

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20080108